Billings Clinic
Especially For:

Clinical Trials

Title   CTSU 40601: Breast Cancer: Neoadjuvant HER2 Positive
Description   CTSU C40601 A Randomized Phase III Trial of Paclitaxel Combined with Trastuzumab, Lapatinib, or Both as Neoadjuvant Treatment of HER2 Positive Breast Cancer
IRB Number   CTSU C40601
Category   Breast
Inclusion/Notes   Stage II and III
Pre Treatment Biopsies
Status   Active
Start Date   01/09/2009
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Joan Koch RN
Contact Email
Phone   (406) 435-7181
Alternate Phone   (406) 255-8400
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.